Skip to main content
Medicine logoLink to Medicine
. 2019 Dec 20;98(51):e18177. doi: 10.1097/MD.0000000000018177

Laryngeal adenoid cystic carcinoma

Three cases reports

Yu Cui a, Lirong Bi b, Le Sun a, Xin Wang a,, Zhanpeng Zhu c
Editor: NA
PMCID: PMC6940171  PMID: 31860963

Abstract

Introduction:

Laryngeal adenoid cystic carcinoma (LACC) is an extremely rare malignant neoplasm. The etiology of LACC remains unknown, and it is characterized by multiple recurrences, slow progression, and late distant metastasis. This study aimed to provide more information regarding the characteristics, diagnosis, and treatment of LACC by analyzing 3 clinical cases and reviewing the literature on this topic.

Patient concerns:

Here, we present all 3 cases of LACC within the period between 2010 and 2019. Dyspnea was the most commonly observed symptom in these patients, followed by hoarseness, pharyngeal paresthesia, and difficulty swallowing.

Diagnosis:

All patients were pathologically confirmed as LACC.

Interventions:

All the patients underwent a combined therapy of surgical resection plus external irradiation.

Outcomes:

The follow-up time was between 2 and 6 years; no local recurrence occurred in any of the 3 patients. Lung metastasis was found in 1 patient 6 years after surgery.

Conclusion:

LACC is usually a slowly progressing cancer; the main treatment methods are surgery and radiotherapy, and the adequate radiotherapy dose should usually be greater than 60 Gy. The 5-year disease-specific survival rate is high; however, distant metastasis may still occur in patients with LACC even beyond 5 years after treatment. Therefore, patients with LACC require long-term surveillance.

Keywords: adenoid cystic carcinoma, follow-up, laryngectomy, larynx, malignant tumors

1. Introduction

Adenoid cystic carcinomas, first described by Robin and Laboulbene in 1853, were previously known as cylindromas.[1] This type of carcinoma mostly occurs in the minor salivary glands, which account for 1% to 5% of all head and neck malignancies.[24] The common sites of adenoid cystic carcinomas are in the salivary glands of the oral cavity, in which the laryngeal adenoid cystic carcinomas (LACC) are sporadic, and account for less than 1% of laryngeal malignancy.[5,6]

The etiology of LACC remains unknown. It has no capsule and grows slowly, but has the ability to invade into surrounding tissues and distant metastasis. It is characterized by neurotropic growth, easy recurrence, and high rate of hematogenous metastasis,[4] with no obvious association with smoking and drinking. Patients with LACC have a long survival period. However, multiple recurrences and late metastasis have been observed in this population. Thus, long-term follow-up is required.[7]

As LACC is rare, this study aimed to provide more information regarding the characteristics, diagnosis, and treatment of this disease by analyzing 3 clinical cases and reviewing the literature on this topic. This study was approved by the Jilin University Ethics Review Board.

2. Cases report

We retrospectively analyzed 3 cases of LACC that were admitted to the First Hospital of Jilin University between 2010 and 2019. The clinical and pathological data were extracted from hospital medical records. We obtained follow-up information by contacting the patients or their family members. All the 3 patients have provided informed consent for publication of the case. The basic characteristics and treatment information of the patients are shown in Table 1. The follow-up data of the patients are shown in Table 2. The final pathological diagnosis in all cases was mixed LACC (see details in Fig. 1 and Table 3), and the proportion of subtypes are shown in Table 3.

Table 1.

Patients’ basic characteristics and therapy.

2.

Table 2.

follow-up information for all three cases.

2.

Figure 1.

Figure 1

Imaging of microscope with laryngeal adenoid cystic carcinoma. (A) Solid pattern on the left side and tubular pattern on the right side (H&E staining, ×200). (B) Invasion of thyroid cartilage with ossification by cribriform pattern and tubular pattern (H&E staining, ×100). (C) Solid pattern adenoid cystic carcinoma invades thyroid cartilage with cartilage ossification (H&E staining, ×200).

Table 3.

Histopathological patterns and the proportion.

2.

2.1. Case 1

Case 1 was a male patient, 38 years old, who was admitted to hospital due to hoarseness accompanied by dyspnea after activities. Physical examination showed annular neoplasm in the subglottic portion, with subglottic stenosis; bilateral vocal cord movement was acceptable, and the neck ultrasound showed enlarged lymph nodes in the left neck. Intraoperative frozen section showed LACC. Therefore, total laryngectomy and left neck dissection were performed. The pathological margin was negative. Clinical diagnosis is LACC (T2N2bM0). Radiotherapy was accepted, and the radiotherapy dose was 66 Gy. Pulmonary metastasis was found 6 years after surgery, and the patient had died.

2.2. Case 2

Case 2 was a male patient, 48 years old, who was admitted to hospital due to laborious breathing and foreign body sensation in pharynx. Physical examination showed annular neoplasm in the subglottic portion, and no obviously enlarged lymph nodes in the neck. The laryngeal computed tomography showed irregular soft tissue shadows in the cricoid cartilage level. Intraoperative frozen section showed LACC, so total laryngectomy was performed. Clinical diagnosis is LACC (T2N0M0). Postoperative pathological margin was negative, radiotherapy was accepted, and the radiotherapy dose was 66 Gy. The follow-up period was 2 years, and the patient was still alive without distant metastasis.

2.3. Case 3

Case 3 was a male patient, 67 years old, admitted to hospital due to laborious breathing and hoarseness. Physical examination showed annular neoplasm in the subglottic portion, no obviously enlarged lymph nodes in the neck, and the neck ultrasound showed multiple thyroid nodules. Intraoperative frozen section showed LACC and nodular goiter. Therefore, total laryngectomy and bilateral subtotal thyroidectomy were performed. Clinical diagnosis is LACC (T2N0M0)—nodular goiter. Immunohistochemical analysis of the specimen supported the diagnosis of LACC, and demonstrated positivity of CD117, P63, and CK7 (Fig. 2), which suggested that the tumor consisted of glandular epithelium and myoepithelium. The diagnosis of the other 2 cases is arrived at similar immunohistochemical result. Postoperative pathological margin was negative, radiotherapy was accepted, and the radiotherapy dose was 60 Gy. The follow-up period was 2 years. The patient was still alive without distant metastasis.

Figure 2.

Figure 2

Imaging of immunohistochemical results of case 3: positivity of CD117 (H&E staining, ×200) (A), P63 (H&E staining, ×400) (B), and CK7 (H&E staining, ×200) (C).

3. Discussion

Adenoid cystic carcinoma originates from large or small salivary glands or mucinous glands of the upper respiratory tract. The salivary glands of the larynx are very rare. Therefore, LACC is relatively rare.[8] The distribution of the disease has been reported to gradually reduce from the supraglottic area to the glottis area and the subglottic area.[8] Ellington et al[9] found that the most common primary site of LACC is indeed the subglottic region (58.2%), followed by the upper glottic area (32.1%) and the glottic area (9.7%). In the majority of cases, the age of disease onset is between 50 and 60 years old.[9,10] Although it is rare that patients with LACC are under 20 years of age, Javadi et al reported a case of a 12-year-old boy with subglottic adenoid cystic carcinoma.[11,12] The symptoms and signs of LACC are closely related to the anatomical location of the tumor. Dyspnea is often associated with subglottic tumors, while glottic tumors are always characterized by pharyngeal paresthesia.[13] In the present study, the location site of all 3 cases was in the subglottic region with a common symptom of dyspnea.

The clinical features of LACC include a high rate of neurological involvement,[2] local invasive growth (in addition to nerve, bone, lymphatic vessels, blood vessels, and muscle involvement), a high recurrence rate, and a low rate of cervical lymph node metastasis (depending on the primary site of the tumor, the oral ACC lymph node metastasis rate can reach 37%).[3,14] This condition is prone to distant metastasis, and even early lesions have the potential for distant metastasis. The most common metastatic organ is the lung, followed by bone and liver, and distant metastasis can still occur after several decades. Imaging evaluation at the time of follow-up is recommended.[4,13] Because of the low incidence, atypical symptoms, and late onset of symptoms, detection of LACC is not easy. Thus, LACC is always in the advanced stage at the time of diagnosis. In addition, LACC has an “inert” biological behavior with a longer survival period. Even local recurrence or distant metastasis (especially in the lungs) can occur after a long period of treatment.[15] Long-term follow-up and intervention are suggested after treatment. In 1 of the present cases, lung metastasis was observed after 6 years of treatment.

Adenoid cystic carcinoma is a basal cell-like malignant tumor that is composed of epithelial and myoepithelial cells. The histopathological classification of this carcinoma can be divided into 3 patterns: tubular, cribriform, and solid. The most commonly observed pattern is the solid type, and the prognosis of this pattern is poor.[1618] The 3 pathological patterns listed above may occur in the same case.[18] One of the classification methods is performed according to the percentage of solid components, which is very convenient for prognosis prediction.[19] All 3 of the cases included in this study belonged to mixed adenoid cystic carcinoma (Fig. 1). It is notable that in the patient in which pulmonary metastases were observed after 6 years of treatment, the cribriform pattern was predominant. Although the patient with pulmonary metastases was predominantly cribriform pattern, not solid pattern, as the number of cases was small, it did not contradict the results reported in the previous literature.

At present, surgery is the most successful method used for the treatment of LACC. It remains a controversial issue whether it is necessary to perform adjuvant radiotherapy or chemotherapy. The majority of scholars believe that adjuvant radiotherapy (mainly postoperative radiotherapy) is needed, and this is recommended as the standard treatment model, which is considered to be superior to surgery alone or radiotherapy alone.[4,16] For LACC in the subglottic region, a total laryngectomy is required, which was performed in all 3 of the present cases; for LACC that occurs in the supraglottic region, the extent of surgery varies according to the surrounding tissue invasion. Ideally, the tumor is completely removed during the first operation. However, as the structure of the head and neck is complex, at diagnosis, the disease is often at the advanced stage, and, at this point, the tumor has often spread along nerves. Thus, complete tumor removal is often difficult.[3,9,20,21] In some cases, the ability to remove the entire tumor is impaired as the pathological examination of the margin is not reliable. Even in cases where the margin is negative, remote nerve spread can still be present.[15]

False-negative margin reports may lead to a clinician mistakenly believing that the tumor has been completely removed, which, in turn, affects the development of follow-up treatment schedule.[19] Furthermore, preoperative evaluation of patients with cervical lymph nodes (cN)+ is feasible for cervical lymph node dissection, while for patients with cN0 it is not. This may be because cervical radiotherapy can also achieve the same effect of neck dissection.[22] However, LACC is located in areas that are rich in lymph nodes, which is recommended for cervical lymph node dissection for the high rate of lymph node metastasis.[23] For all of the cases in the present study, cervical lymph node dissection was performed.

It is generally believed that patients with positive margins, margins close to the tumor, or pathological findings of neurological involvement should be treated with radiotherapy or routine postoperative radiotherapy. Appropriate postoperative radiotherapy can improve the local control rate and tumor-free survival rate. Furthermore, preoperative radiotherapy can increase the tumor resection rate. The radiation field of radiotherapy should include the peritumoral nerve pathway because of neurological involvement. The cN0 patient may not include the neck area, but the neck-preventive irradiation may be feasible for tumors located in the rich lymph node site.[24] The adequate radiotherapy dose is a prerequisite for the efficacy and should usually be greater than 60 Gy. Relapse is often observed if the dose for postoperative radiotherapy or radiotherapy is less than 60 Gy.[25]

It has been confirmed that adenoid cystic carcinoma often undergoes early neurological and hematogenous metastasis at early stages.[2,3,13,26] Sometimes, metastasis can occur after many years of primary tumor treatment. Moukarbel et al[27] reported, in a review of 15 cases, that the disease-specific survival rate was 69% and 49% at 5 and 10 years, respectively. In the present cases, the 5-year disease-specific survival rate was 100%. However, lung metastasis was observed in 1 patient 6 years after surgery. This indicates that the 5-year disease-specific survival rate is pretty high. However, distant metastasis may occur more than 5 years after treatment. Therefore, in cases of adenoid cystic carcinoma, long-term follow-up is required after treatment.

4. Conclusions

In conclusion, Although LACC is usually a slowly progressing cancer, late diagnosis can be fatal in some cases. Distant metastasis may still occur in patients with LACC even beyond 5 years after treatment. Therefore, patients with LACC require long-term surveillance.

Acknowledgment

This manuscript has been edited and proofread by Medjaden Bioscience Limited.

Author contributions

Resources: Lirong Bi.

Supervision: Le Sun.

Writing – original draft: Yu Cui.

Writing – review & editing: wang xin, Zhanpeng Zhu.

Footnotes

Abbreviation: LACC = laryngeal adenoid cystic carcinoma.

How to cite this article: Cui Y, Bi L, Sun L, Wang X, Zhu Z. Laryngeal adenoid cystic carcinoma: three cases reports. Medicine. 2019;98:51(e18177).

Z.Z. and X.W. contributed equally and should be co-correspondent authors.

The authors have no funding and conflicts of interest to disclose.

References

  • [1].Tauxe WN, McDonald JR, Devine KD. A century of cylindromas: short review and report of 27 adenoid cystic carcinomas arising in the upper respiratory passages. Arch Otolaryngol 1962;75:364–76. [DOI] [PubMed] [Google Scholar]
  • [2].Ali S, Yeo JC, Magos T, et al. Clinical outcomes of adenoid cystic carcinoma of the head and neck: a single institution 20-year experience. J Laryngol Otol 2016;130:680–5. [DOI] [PubMed] [Google Scholar]
  • [3].Amit M, Na’ara S, Trejo-Leider L, et al. Defining the surgical margins of adenoid cystic carcinoma and their impact on outcome: an international collaborative study. Head Neck 2017;39:1008–14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [4].Husain Q, Kanumuri VV, Svider PF, et al. Sinonasal adenoid cystic carcinoma: systematic review of survival and treatment strategies. Otolaryngol Head Neck Surg 2013;148:29–39. [DOI] [PubMed] [Google Scholar]
  • [5].Batsakis JG, Luna MA, el-Naggar AK. Nonsquamous carcinomas of the larynx. Ann Otol Rhinol Laryngol 1992;101:1024–6. [DOI] [PubMed] [Google Scholar]
  • [6].Wang MC, Liu CY, Li WY, et al. Salivary gland carcinoma of the larynx. J Chin Med Assoc 2006;69:322–5. [DOI] [PubMed] [Google Scholar]
  • [7].Zvrko E, Golubovic M. Laryngeal adenoid cystic carcinoma. Acta Otorhinolaryngol Ital 2009;29:279–82. [PMC free article] [PubMed] [Google Scholar]
  • [8].Liu W, Chen X. Adenoid cystic carcinoma of the larynx: a report of six cases with review of the literature. Acta Otolaryngol 2015;135:489–93. [DOI] [PubMed] [Google Scholar]
  • [9].Ellington CL, Goodman M, Kono SA, et al. Adenoid cystic carcinoma of the head and neck: Incidence and survival trends based on 1973-2007 Surveillance, Epidemiology, and End Results data. Cancer 2012;118:4444–51. [DOI] [PubMed] [Google Scholar]
  • [10].Lloyd S, Yu JB, Wilson LD, et al. Determinants and patterns of survival in adenoid cystic carcinoma of the head and neck, including an analysis of adjuvant radiation therapy. Am J Clin Oncol 2011;34:76–81. [DOI] [PubMed] [Google Scholar]
  • [11].Shin YJ, Percodani J, Coste EU, et al. [Adenoid cystic carcinoma of the larynx. A case report and review of the literature]. Rev Laryngol Otol Rhinol (Bord) 1998;119:105–8. [PubMed] [Google Scholar]
  • [12].Javadi M, Bafrouee FM, Mohseni M, et al. Laryngeal adenoid cystic carcinoma in a child: a case report. Ear Nose Throat J 2002;81:34–5. [PubMed] [Google Scholar]
  • [13].Jang S, Patel PN, Kimple RJ, et al. Clinical outcomes and prognostic factors of adenoid cystic carcinoma of the head and neck. Anticancer Res 2017;37:3045–52. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [14].Unsal AA, Chung SY, Zhou AH, et al. Sinonasal adenoid cystic carcinoma: a population-based analysis of 694 cases. Int Forum Allergy Rhinol 2017;7:312–20. [DOI] [PubMed] [Google Scholar]
  • [15].Balamucki CJ, Amdur RJ, Werning JW, et al. Adenoid cystic carcinoma of the head and neck. Am J Otolaryngol 2012;33:510–8. [DOI] [PubMed] [Google Scholar]
  • [16].Coca-Pelaz A, Rodrigo JP, Bradley PJ, et al. Adenoid cystic carcinoma of the head and neck: an update. Oral Oncol 2015;51:652–61. [DOI] [PubMed] [Google Scholar]
  • [17].Ikawa H, Koto M, Takagi R, et al. Prognostic factors of adenoid cystic carcinoma of the head and neck in carbon-ion radiotherapy: the impact of histological subtypes. Radiother Oncol 2017;123:387–93. [DOI] [PubMed] [Google Scholar]
  • [18].van Weert S, Reinhard R, Bloemena E, et al. Differences in patterns of survival in metastatic adenoid cystic carcinoma of the head and neck. Head Neck 2017;39:456–63. [DOI] [PubMed] [Google Scholar]
  • [19].van Weert S, van der Waal I, Witte BI, et al. Histopathological grading of adenoid cystic carcinoma of the head and neck: analysis of currently used grading systems and proposal for a simplified grading scheme. Oral Oncol 2015;51:71–6. [DOI] [PubMed] [Google Scholar]
  • [20].Thompson LD, Penner C, Ho NJ, et al. Sinonasal tract and nasopharyngeal adenoid cystic carcinoma: a clinicopathologic and immunophenotypic study of 86 cases. Head Neck Pathol 2014;8:88–109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [21].Sanghvi S, Patel NR, Patel CR, et al. Sinonasal adenoid cystic carcinoma: comprehensive analysis of incidence and survival from 1973 to 2009. Laryngoscope 2013;123:1592–7. [DOI] [PubMed] [Google Scholar]
  • [22].Amit M, Na’ara S, Sharma K, et al. Elective neck dissection in patients with head and neck adenoid cystic carcinoma: an international collaborative study. Ann Surg Oncol 2015;22:1353–9. [DOI] [PubMed] [Google Scholar]
  • [23].Amit M, Binenbaum Y, Sharma K, et al. Incidence of cervical lymph node metastasis and its association with outcomes in patients with adenoid cystic carcinoma. An international collaborative study. Head Neck 2015;37:1032–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [24].Choi Y, Kim SB, Yoon DH, et al. Clinical characteristics and prognostic factors of adenoid cystic carcinoma of the head and neck. Laryngoscope 2013;123:1430–8. [DOI] [PubMed] [Google Scholar]
  • [25].Chen AM, Bucci MK, Weinberg V, et al. Adenoid cystic carcinoma of the head and neck treated by surgery with or without postoperative radiation therapy: prognostic features of recurrence. Int J Radiat Oncol Biol Phys 2006;66:152–9. [DOI] [PubMed] [Google Scholar]
  • [26].Seong SY, Hyun DW, Kim YS, et al. Treatment outcomes of sinonasal adenoid cystic carcinoma: 30 cases from a single institution. J Craniomaxillofac Surg 2014;42:e171–5. [DOI] [PubMed] [Google Scholar]
  • [27].Moukarbel RV, Goldstein DP, O'Sullivan B, et al. Adenoid cystic carcinoma of the larynx: a 40-year experience. Head Neck 2008;30:919–24. [DOI] [PubMed] [Google Scholar]

Articles from Medicine are provided here courtesy of Wolters Kluwer Health

RESOURCES